Arcoma AB Price To Sales vs. Book Value Per Share
| ARCOMA Stock | SEK 10.55 0.10 0.96% |
For Arcoma AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Arcoma AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Arcoma AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Arcoma AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Arcoma AB over time as well as its relative position and ranking within its peers.
Arcoma |
Arcoma AB Book Value Per Share vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Arcoma AB's current stock value. Our valuation model uses many indicators to compare Arcoma AB value to that of its competitors to determine the firm's financial worth. Arcoma AB is number one stock in price to sales category among its peers. It also is number one stock in book value per share category among its peers creating about 3.58 of Book Value Per Share per Price To Sales. Comparative valuation analysis is a catch-all model that can be used if you cannot value Arcoma AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arcoma AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Arcoma Book Value Per Share vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Arcoma AB |
| = | 0.97 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Arcoma AB |
| = | 3.48 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Arcoma Book Value Per Share Comparison
Arcoma AB is currently under evaluation in book value per share category among its peers.
Arcoma AB Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Arcoma AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Arcoma AB will eventually generate negative long term returns. The profitability progress is the general direction of Arcoma AB's change in net profit over the period of time. It can combine multiple indicators of Arcoma AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden.
Arcoma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Arcoma AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Arcoma AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Arcoma AB's important profitability drivers and their relationship over time.
Use Arcoma AB in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arcoma AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcoma AB will appreciate offsetting losses from the drop in the long position's value.Arcoma AB Pair Trading
Arcoma AB Pair Trading Analysis
The ability to find closely correlated positions to Arcoma AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arcoma AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arcoma AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arcoma AB to buy it.
The correlation of Arcoma AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arcoma AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arcoma AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arcoma AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Arcoma AB position
In addition to having Arcoma AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Arcoma Stock
To fully project Arcoma AB's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Arcoma AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Arcoma AB's income statement, its balance sheet, and the statement of cash flows.